You are here

Article metrics

Article menu
Download PDFPDF
Commentary
Selective LOXL2 inhibition: potent antifibrotic effects in ongoing fibrosis and fibrosis regression

 

Online download statistics by month:

Online download statistics by month: February 2017 to March 2024

AbstractFullPdf
Feb 20174934
Mar 20173008073
Apr 2017902115
May 2017512817
Jun 2017642412
Jul 20171112420
Aug 20176047865
Sep 20171992721
Oct 20171472825
Nov 20171041612
Dec 2017941711
Jan 2018124129
Feb 201896158
Mar 20181212112
Apr 2018145199
May 201812386
Jun 201895311
Jul 201810977
Aug 20185012
Sep 20187044
Oct 201872919
Nov 20184467
Dec 20184176
Jan 201968610
Feb 20193599
Mar 20193055
Apr 20193724
May 20195666
Jun 20193354
Jul 20195440
Aug 20196000
Sep 20192421
Oct 201951104
Nov 20194283
Dec 20191621
Jan 20203731
Feb 20205732
Mar 20204433
Apr 20201400
May 20202011
Jun 20203472
Jul 20204271
Aug 20201511
Sep 20206400
Oct 20204751
Nov 20205366
Dec 20204853
Jan 20212800
Feb 20215150
Mar 20214931
Apr 20216321
May 20215572
Jun 2021772
Jul 2021330
Aug 2021110
Sep 2021430
Oct 20219921
Nov 20219763
Dec 20214050
Jan 20228283
Feb 20227460
Mar 20228984
Apr 202268132
May 202213281
Jun 202214111
Jul 20229342
Aug 202212530
Sep 2022180165
Oct 2022201172
Nov 202210962
Dec 202213454
Jan 20238820
Feb 202319774
Mar 202315886
Apr 202322770
May 202313621
Jun 20236510
Jul 20235510
Aug 20238051
Sep 20238921
Oct 20235320
Nov 20236300
Dec 202320142
Jan 202410832
Feb 202411211
Mar 202411520
Total7556744497